Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients

Journal of Clinical Microbiology

Volumn 42, Issue 11, 2004, Pages 5189-5198

  Watzinger, F ^a   Suda, M ^a   Preuner, S ^a   Baumgartinger, R ^a   Ebner, K ^a   Baskova, L ^a   Niesters, H G M ^c   Lawitschka, A ^b   Lion, T ^a  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR;

ADOLESCENT; ARTICLE; BK VIRUS; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENTEROVIRUS; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN ADENOVIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; IMMUNE DEFICIENCY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; JC VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PARVOVIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REPRODUCIBILITY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENSITIVITY AND SPECIFICITY; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS LOAD;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TAQ POLYMERASE; VIRUS DISEASES; VIRUSES;

ADENOVIRIDAE; BK POLYOMAVIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; ENTEROVIRUS; HERPESVIRIDAE; HUMAN ADENOVIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HUMAN PARAINFLUENZA VIRUS 1; HUMAN PARAINFLUENZA VIRUS 2; HUMAN PARAINFLUENZA VIRUS 3; INFLUENZA VIRUS; INFLUENZAVIRUS A; INFLUENZAVIRUS B; JC VIRUS; PARVOVIRUS; PNEUMOVIRUS; POLYOMAVIRUS; RESPIRATORY SYNCYTIAL VIRUS; SIMPLEXVIRUS;

EID: 8644237322     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.11.5189-5198.2004     Document Type: Article

References (33)

1. Abdallah, A., K. E. Rowland, S. K. Schepetiuk, L. B. To, and P. Bardy. 2003. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant. 32:195-203.
2. Akiyama, H., T. Kurosu, C. Sakashita, T. Inoue, S. Mori, K. Ohashi, S. Tanikawa, H. Sakamaki, Y. Onozawa, Q. Chen, H. Zheng, and T. Kitamura. 2001. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin. Infect. Dis. 32:1325-1330.
3. Cervia, J., B. Kaplan, S. Schuval, and S. Weiss. 2003. Virologic testing in the management of perinatal HIV exposure. AIDS Read. 13:39-41.
4. Dini, G., E. Castagnola, P. Comoli, M. J. van Tol, and J. M. Vossen. 2001. Infections after stem cell transplantation in children: state of the art and recommendations. Bone Marrow Transplant. 28(Suppl. 1):S18-S21.
5. Emery, V. C., A. V. Cope, E. F. Bowen, D. Gor, and P. D. Griffiths. 1999. The dynamics of human cytomegalovirus replication in vivo. J. Exp. Med. 190:177-182.
6. Emery, V. C., C. A. Sabin, A. V. Cope, D. Gor, A. F. Hassan-Walker, and P. D. Griffiths. 2000. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032-2036.
7. Fischmeister, G., P. Wiesbauer, H. M. Holzmann, C. Peters, M. Eibl, and H. Gadner. 2000. Enteroviral meningoencephalitis in immunocompromised children after matched unrelated donor-bone marrow transplantation. Pediatr. Hematol. Oncol. 17:393-399.
8. Gartner, B. C., H. Schafer, K. Marggraff, G. Eisele, M. Schafer, D. Dilloo, K. Roemer, H. J. Laws, M. Sester, U. Sester, H. Einsele, and N. Mueller-Lantzsch. 2002. Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease. J. Clin. Microbiol. 40:351-358.
9. Gustafsson, A., V. Levitsky, J. Z. Zou, T. Frisan, T. Dalianis, P. Ljungman, O. Ringden, J. Winiarski, I. Ernberg, and M. G. Masucci. 2000. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 95:807-814.
10. Hassan, I. A., R. Chopra, R. Swindell, and K. J. Mutton. 2003. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Bone Marrow Transplant. 32:73-77.
11. Hodinka, R. L. 1998. The clinical utility of viral quantitation using molecular methods. Clin. Diagn. Virol. 10:25-47.
12. Ishizaki, Y., J. Tezuka, S. Ohga, A. Nomura, N. Suga, R. Kuromaru, K. Kusuhara, Y. Mizuno, N. Kasuga, and T. Hara. 2003. Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella. J. Infect. 47:133-138.
13. Jungkind, D. 2001. Automation of laboratory testing for infectious diseases using the polymerase chain reaction-our past, our present, our future. J. Clin. Virol. 20:1-6.
14. Kumar, R., N. Vandegraaff, L. Mundy, C. J. Burrell, and P. Li. 2002. Evaluation of PCR-based methods for the quantitation of integrated HIV-1 DNA. J. Virol. Methods 105:233-246.
15. Lankester, A. C., M. J. van Tol, J. M. Vossen, A. C. Kroes, and E. Claas. 2002. Epstein-Barr virus (EBV)-DNA quantification in pediatric allogenic stem cell recipients: prediction of EBV-associated lymphoproliferative disease. Blood 99:2630-2631.
16. Larsson, S., C. Soderberg-Naucler, F. Z. Wang, and E. Moller. 1998. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 38:271-278.
17. Leruez-Ville, M., M. Ouachee, R. Delarue, A. S. Sauget, S. Blanche, A. Buzyn, and C. Rouzioux. 2003. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J. Clin. Microbiol. 41:2040-2046.
18. Limaye, A. P., M. L. Huang, W. Leisenring, L. Stensland, L. Corey, and M. Boeckh. 2001. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. J. Infect. Dis. 183:377-382.
19. Lion, T. 2001. Current recommendations for positive controls in RT-PCR assays. Leukemia 15:1033-1037.
20. Lion, T., R. Baumgartinger, F. VVatzinger, S. Matthes-Martin, M. Suda, S. Preuner, B. Futterknecht, A. Lawitschka, C. Peters, U. Potschger, and H. Gadner. 2003. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102:1114-1120.
21. O'Doherty, U., W. J. Swiggard, D. Jeyakumar, D. McGain, and M. H. Malim. 2002. A sensitive, quantitative assay for human immunodeficiency virus type 1 integration. J. Virol. 76:10942-10950.
22. Pas, S. D., E. Fries, R. A. De Man, A. D. Osterhaus, and H. G. Niesters. 2000. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J. Clin. Microbiol. 38:2897-2901.
23. Reusser, P. 2002. Challenges and options in the management of viral infections after stem cell transplantation. Support. Care Cancer 10:197-203.
24. Sashihara, J., K. Tanaka-Taya, S. Tanaka, K. Amo, H. Miyagawa, G. Hosoi, T. Taniguchi, T. Fukui, N. Kasuga, T. Aono, M. Sako, J. Hara, K. Yamanishi, and S. Okada. 2002. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 100:2005-2011.
25. Savoie, A., C. Perpete, L. Carpentier, J. Joncas, and C. Alfieri. 1994. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2715-2722.
26. Schilham, M. W., E. C. Claas, W. van Zaane, B. Heemskerk, J. M. Vossen, A. C. Lankester, R. E. Toes, M. Echavarria, A. C. Kroes, and M. J. van Tol. 2002. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin. Infect. Dis. 35:526-532.
27. Schutten, M., and H. G. Niesters. 2001. Clinical utility of viral quantification as a tool for disease monitoring. Expert Rev. Mol. Diagn. 1:153-162.
28. Segovia, J. C., G. Guenechea, J. M. Gallego, J. M. Almendral, and J. A. Bueren. 2003. Parvovirus infection suppresses long-term repopulating hematopoietic stem cells. J. Virol. 77:8495-8503.
29. Sirvent-Von Bueltzingsloewen, A., P. Morand, M. Buisson, G. Souillet, H. Chambost, J. L. Bosson, and P. Bordigoni. 2002. A prospective study of Epstein-Barr virus load in 85 hematopoietic stem cell transplants. Bone Marrow Transplant. 29:21-28.
30. van Esser, J. W., H. G. Niesters, S. F. Thijsen, E. Meijer, A. D. Osterhaus, K. C. Wolthers, C. A. Boucher, J. W. Gratama, L. M. Budel, H. B. van der, A. M. van Loon, B. Lowenberg, L. F. Verdonck, and J. J. Cornelissen. 2001. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br. J. Haematol. 113:814-821.
31. van Esser, J. W., H. G. Niesters, H. B. van der, E. Meijer, A. D. Osterhaus, J. W. Gratama, L. F. Verdonck, B. Lowenberg, and J. J. Cornelissen. 2002. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 99:4364-4369.
32. van Esser, J. W., H. B. van der, E. Meijer, H. G. Niesters, R. Trenschel, S. F. Thijsen, A. M. van Loon, F. Frassoni, A. Bacigalupo, U. W. Schaefer, A. D. Osterhaus, J. W. Gratama, B. Lowenberg, L. F. Verdonck, and J. J. Cornelissen. 2001. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 98:972-978.
33. Wagner, H. J., M. Wessel, W. Jabs, F. Smets, L. Fischer, G. Offner, and P. Bucsky. 2001. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation 72:1012-1019.